Proactive R&D Asset & Facilities Management for Visibility, Sustainability

& Operational Excellence

The Covid-19 global pandemic presented Lab Operations and Facility Management leaders with a unique set of challenges to keep research operations going, and ensure EHS compliance, whilst staying one step ahead to prepare for organization’s expansion plans. The 4th LAFM meeting is the one and only industry-led summit for the Lab Ops, Asset Management, Lab IT & FM leaders in the life science community to share lessons learned in 2020 & 2021; allowing you to hear how your peers and senior leaders have adapted through radical changes to shockproof your operational strategy.

3 Days I 32 Speakers I 4 Workshops I 2 Streams I 1 Careers Evening

2021 key themes:

Digitalizing Asset Management

Implement a streamlined asset management system to regain visibility and control of spends and maximize asset lifecycle for capital efficiency.

 

Flexible Facility Management & Design

With biotech flourishing and pharma looking for smarter space solutions, align your current and future facility planning with your organisation’s expansion needs.

 

Strategic Sourcing & Procurement

Evaluate supply chain risks for critical lab consumables and re-examine the relationship between lab operations and procurement.

 

Intelligent Lab IT & Informatics

Progressive lab informatics is no longer a ‘nice to have’ but a need. Bulletproof your cyber security, data storage and adapt to the digital lab of the future.

 

Revolutionary EHS & Sustainability

Join the journey to carbon neutrality. Discover new sustainable solutions to energy usage and consumables from a range of company sizes

Who Attends?

LAMF who attends
LAMF who attends (1)
LAMF who attends (2)
LAMF who attends (3)

*based on previous events' statistics 

2020 Attendees included

LAFM - Previous Attendees

Don't Just Take Our Word For It:

"The content shared at the conference is current and informative and I value the networking with industry peers."
Director Global Procurement, R&D, Eli Lilly

"We really enjoyed the event and that the subject has huge potential as pressures continue to drive different ways of managing lab assets and environments."
iLS Group Director, CBRE

"I found the conference to be very informative with nice takeaways."
Lab Services Supervisor, AstraZeneca

"It was a very interesting 2 days with some great insights from biotech and pharma."
Associate Director, Facilities & Lab Operations, Jounce Therapeutics